Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384965 | SCV001584672 | pathogenic | not provided | 2023-07-16 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs558628181, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MAK-related conditions. ClinVar contains an entry for this variant (Variation ID: 1072281). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg3*) in the MAK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MAK are known to be pathogenic (PMID: 21148103, 21825139, 24938718, 29781741). |
Baylor Genetics | RCV004557581 | SCV005049481 | likely pathogenic | Retinitis pigmentosa 62 | 2023-12-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003973223 | SCV004795008 | likely benign | MAK-related disorder | 2019-03-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |